Pharma Firms Swap Assets | April 28, 2014 Issue - Vol. 92 Issue 17 | Chemical & Engineering News
Volume 92 Issue 17 | p. 5 | News of The Week
Issue Date: April 28, 2014 | Web Date: April 25, 2014

Pharma Firms Swap Assets

Pharmaceuticals: Novartis, GSK, and Lilly trade businesses to create more focused companies
Department: Business
Keywords: pharmaceuticals, vaccines, animal health, acquisitions

Novartisis exiting vaccines, GlaxoSmithKline is shedding oncology drugs, and Eli Lilly & Co. is boosting its animal health business through a suite of multi-billion-dollar transactions with each other. All told, the big pharma companies expect the swaps to strengthen their market positions at a time when all three are struggling to grow.

In the biggest transaction, Novartis will pay up to $16 billion to acquire GSK’s . . .

You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society